Evidence map›Paper›PMID 38133049›Full record

ArticleNanomaterials (Basel, Switzerland)2023

Phase of Topological Lattice with Leaky Guided Mode Resonance.

Heejin Choi, Seonyeong Kim, Markus Scherrer, Kirsten Moselund, Chang-Won Lee

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Heejin ChoiInstitute of Advanced Optics and Photonics, Hanbat National University, Daejeon 34158, Republic of Korea.
Seonyeong KimLaboratory of Nano and Quantum Technologies, Paul Scherrer Institut, 5232 Villigen, Switzerland.
Markus ScherrerIBM Research Europe-Zürich, 8803 Rüschlikon, Switzerland.ORCID 0009-0001-1789-1052
Kirsten MoselundLaboratory of Nano and Quantum Technologies, Paul Scherrer Institut, 5232 Villigen, Switzerland.
Chang-Won LeeInstitute of Advanced Optics and Photonics, Hanbat National University, Daejeon 34158, Republic of Korea.ORCID 0000-0003-0546-0439
Hanbat National University · KRPaul Scherrer Institute · CHIBM Research - Zurich · CH

Funding

National Research Foundation of Korea (NRF) 2019K1A3A1A14064815National Research Foundation of Korea (NRF) 2020R1I1A3071811National Research Foundation of Korea (NRF) 2022 M3H3A1085772Swiss Science and Technology Programme (KSSTP) of SNF 188173
6 · The paper itself

Abstract

Topological nature in different areas of physics and electronics has often been characterized and controlled through topological invariants depending on the global properties of the material. The validity of bulk-edge correspondence and symmetry-related topological invariants has been extended to non-Hermitian systems. Correspondingly, the value of geometric phases, such as the Pancharatnam-Berry or Zak phases, under the adiabatic quantum deformation process in the presence of non-Hermitian conditions, are now of significant interest. Here, we explicitly calculate the Zak phases of one-dimensional topological nanobeams that sustain guided-mode resonances, which lead to energy leakage to a continuum state. The retrieved Zak phases show as zero for trivial and as π for nontrivial photonic crystals, respectively, which ensures bulk-edge correspondence is still valid for certain non-Hermitian conditions.

Indexed as

guided-mode resonancenon-Hermitianphotonic crystaltopological invariantsZak phases

Identifiers

PMID38133049
PMCPMC10745808
OpenAlexW4389893525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.